Can GLP-1s Treat Cancer? What the Latest Science Says About Ozempic’s Newest Benefit

GLP-1 receptor agonists, including Ozempic, show potential in reducing cancer risk through weight loss, inflammation reduction, and metabolic improvements. Early studies link their use to a 30-35% lower breast cancer incidence in women and reduced risks for colorectal, endometrial, ovarian, liver, and brain cancers.